Guildford, UK, 8 September 2014: ReNeuron Group plc (AIM: RENE), a leading UK-based stem cell therapy company, announces the appointment of Olav Hellebø, a highly experienced pharmaceutical executive, as the Company’s new Chief Executive Officer, with immediate effect.

More…

Back